On the Ceramic Front: BIPH News Release. My Further comments at conclusion of cut and paste.
++++++++++++++++++++++
Press Release Source: Biophan Technologies, Inc.
Biophan to Demonstrate New Ceramic Motors for Medical Device Applications at Major Industry Conference
Tuesday January 11, 1:34 pm ET
Advanced Technology Enables High-Precision Implantable Drug Delivery Systems and Other Uses
ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan. 11, 2005-- Biophan Technologies, Inc. (OTCBB: BIPH - News), a developer of next-generation biomedical technology, will demonstrate its proprietary ceramic motors for use in a wide range of medical and life science devices at the Medical Design and Manufacturing West (MD&M West) conference, January 10-12, at the Anaheim Convention Center in Anaheim, California. The announcement was made by Michael Weiner, CEO of Biophan. Biophan is the exclusive worldwide distributor for medical applications of the SQUIGGLE(TM) ceramic motor, produced by New Scale Technologies.
ADVERTISEMENT
The MD&M West conference, organized by Canon Communications, LLC, is one of the world's largest meetings for medical device designers and manufacturers. It is being attended by thousands of key designers, decision-makers, and medical device industry executives from the United States, Europe, and Asia.
Biophan is showcasing innovative solutions based on its patent-pending direct linear drive motor constructed of advanced ceramic materials. The motor's unique, high-precision design involves only four parts--compared with hundreds for previously available products--that affords exceptionally high levels of dependability and performance. The SQUIGGLE motor offers a new positioning solution and can be easily scaled to fit a variety of sizes and advanced biomedical devices, including implantable drug delivery devices such as insulin pumps and implantable drug pumps, as well as precision dosage metering and microfluidic devices.
"The piezoelectric ceramic technology we have perfected allows the SQUIGGLE motor to be manufactured in a wide range of sizes and configurations, especially at very small sizes and low power," explained David Henderson, President of New Scale Technologies and inventor of this motor. "Our technology provides substantial advantages over other available biomedical motors. These advantages, such as safety and compatibility with Magnetic Resonance Imaging (MRI), have the potential to significantly improve the options available to the health care and bioscience industries."
Additional technical features of the SQUIGGLE ultrasonic motor includes nanometer precision, zero magnetic fields, no ferromagnetic materials, ultra-low outgassing, negligible heating, quiet movement, and consistent operation over a wide temperature range. The SQUIGGLE motors have been demonstrated from room temperature to 100 degrees Kelvin--or some 173 degrees below the freezing point of water. NASA's Goddard Space Flight Center is evaluating the ceramic motor technology for use at 4 degrees Kelvin--nearly absolute zero--for space applications.
Biophan will also highlight other advanced technologies at the MD&M West conference, including technologies for enabling interventional surgical devices or implants to be made MRI-safe and compatible. These technologies are being developed to enable a new generation of MRI-guided surgical procedures. The Company will also feature its recently announced patented anti-antenna technology for improving the safety of medical implants under MRI.
"We're very excited about highlighting our ceramic motor designs as well as our other recent achievements in development of medical device solutions," said Mr. Weiner. "Biophan is at the forefront of research and development of the next generation of biomedical devices, and our proprietary technologies advance the capabilities of devices across a wide spectrum of diagnostic and therapeutic procedures."
Biophan will be working with the medical device engineering community to use the Company's innovative ceramic motor and its MRI safety and imageability technologies to enable a range of new health-care and life-enhancing products.
About Biophan Technologies
Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers, and interventional surgical devices such as catheters and guidewires, as well as stents and other implants that can be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 104 U.S. patents, licenses, or applications. This total includes 25 issued U.S. patents, 11 recently-allowed applications that will issue as patents in the near future, and 68 pending applications at various stages of examination at the U.S. Patent and Trademark Office. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific (NYSE: BSX - News) and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements included in this press release may constitute forward-looking statements. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of Biophan's MRI technologies; the approval of Biophan's patent applications; the successful implementation of Biophan's research and development programs; the acceptance by the market of Biophan's products; competition; and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in Biophan's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Biophan's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and Biophan undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
--------------------------------------------------------------------------------
Contact:
Biophan Technologies, Inc.
Carolyn Hotchkiss, 585-214-2407
or
(Press Interviews)
Jennifer Gould, 212-843-8037
--------------------------------------------------------------------------------
Source: Biophan Technologies, Inc.
++++++++++++++++++++
Real conjecture:
Ceramics in space. Well, we all remember shuttle heat tiles, but what of the newest NASA and Defense Dept."black" applications????
Ramjets with varying thrust chamber shapes, hydrogen fuel burning? Ceramics at near absolute 0Kelvin. From Micro to Macro ceramics needed. Heck, one of the chefs on a TV show was using a ceramic looking blade the other night. How 'bout a ceramic razor blade assy for a triple or quadra track???
Chuckman: If you put Velcro on a belly band you can lock the laptop in place and it won't slip when you type! Great to hear you're recovering. Get up and around soon.
Stakddek
